By Emmanuel Hanon, Senior Vice President, Head of Vaccines Research & Development, GSK
Content related to Vaccine Technology:
Calixar and VirPath develop an innovative manufacturing process for high performance influenza vaccines
By Andrew Lloyd & Associates
By M. Babu Medi and Ramesh Chintala, Vaccine Drug Product Development, Merck & Co, Inc and Akhilesh Bhambhani, Novel Adjuvants, Formulation and Delivery Technologies, Merck & Co, Inc.
By Abina M. Crean & Anne C. Moore, School of Pharmacy, University College Cork and Conor O’Mahony, Tyndall National Institute, University College Cork
By Howard Smith, Technical and Commercial Manager, Cambridge Biostability